These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16145732)

  • 1. [Development of dermatomyositis in a woman with rheumatoid arthritis treated with leflunomide].
    Gómez Rodríguez N; Zulaica Garate A
    An Med Interna; 2005 Jun; 22(6):300-1. PubMed ID: 16145732
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasculitis occurring during leflunomide therapy.
    Holm EA; Balslev E; Jemec GB
    Dermatology; 2001; 203(3):258-9. PubMed ID: 11701983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unusual overdose of leflunomide in a patient with rheumatoid arthritis.
    Kamali S; Kasapoglu E; Uysal M; Inanc M; Gul A
    Ann Pharmacother; 2004; 38(7-8):1320-1. PubMed ID: 15138298
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe infections following leflunomide therapy for rheumatoid arthritis.
    Grover R; Dhir V; Aneja R; Arya V; Galle A; Marwaha V; Kumar A
    Rheumatology (Oxford); 2006 Jul; 45(7):918-20. PubMed ID: 16717066
    [No Abstract]   [Full Text] [Related]  

  • 5. Leflunomide for the treatment of rheumatoid arthritis.
    Miceli-Richard C; Dougados M
    Expert Opin Pharmacother; 2003 Jun; 4(6):987-97. PubMed ID: 12783594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-glomerular basement membrane antibody-associated renal failure in a patient with leflunomide-treated rheumatoid arthritis.
    Bruyn GA; Veenstra RP; Halma C; Grond J
    Arthritis Rheum; 2003 Apr; 48(4):1164-5. PubMed ID: 12687568
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug hypersensitivity syndrome induced by leflunomide].
    Mohty R; Chaby G; Pannier M; Defossez C; Denoeux JP; Lok C
    Ann Dermatol Venereol; 2003 May; 130(5):551-2. PubMed ID: 12843836
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 5. Leflunomide and mizoribine].
    Sawada T
    Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2929-35. PubMed ID: 22175133
    [No Abstract]   [Full Text] [Related]  

  • 9. Leflunomide.
    Cohen SB; Iqbal I
    Int J Clin Pract; 2003 Mar; 57(2):115-20. PubMed ID: 12661795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leflunomide: new antirheumatic drug. Effect on pregnancy outcomes.
    Kozer E; Moretti ME; Koren G
    Can Fam Physician; 2001 Apr; 47():721-2. PubMed ID: 11340750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide-associated tuberculosis?
    Hocevar A; Rozman B; Praprotnik S; Lestan B; Erzen D; Petric V; Tomsic M
    Rheumatology (Oxford); 2006 Feb; 45(2):228-9. PubMed ID: 16319103
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of a leg ulcer occurring in a rheumatoid arthritis patient under leflunomide therapy.
    Knab J; Goos M; Dissemond J
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):243-6. PubMed ID: 15752303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weekly dose of leflunomide for the treatment of refractory rheumatoid arthritis: an open pilot comparative study.
    Jakez-Ocampo J; Richaud-Patin Y; Simón JA; Llorente L
    Joint Bone Spine; 2002 May; 69(3):307-11. PubMed ID: 12102278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathy associated with leflunomide: a case series.
    Martin K; Bentaberry F; Dumoulin C; Longy-Boursier M; Lifermann F; Haramburu F; Dehais J; Schaeverbeke T; Bégaud B; Moore N
    Ann Rheum Dis; 2005 Apr; 64(4):649-50. PubMed ID: 15769926
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.
    Smolen JS; Kalden JR; Scott DL; Rozman B; Kvien TK; Larsen A; Loew-Friedrich I; Oed C; Rosenburg R
    Lancet; 1999 Jan; 353(9149):259-66. PubMed ID: 9929017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
    Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab and leflunomide combination therapy in rheumatoid arthritis: an open-label study.
    Kiely PD; Johnson DM
    Rheumatology (Oxford); 2002 Jun; 41(6):631-7. PubMed ID: 12048288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity pneumonitis associated with leflunomide therapy.
    Martin N; Innes JA; Lambert CM; Turnbull CM; Wallace WA
    J Rheumatol; 2007 Sep; 34(9):1934-7. PubMed ID: 17611977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leflunomide-associated progressive multifocal leukoencephalopathy.
    Rahmlow M; Shuster EA; Dominik J; Deen HG; Dickson DW; Aksamit AJ; Robles HA; Freeman WD
    Arch Neurol; 2008 Nov; 65(11):1538-9. PubMed ID: 19001176
    [No Abstract]   [Full Text] [Related]  

  • 20. Leflunomide and methotrexate.
    Laan RF; van Riel PL; van de Putte LB
    Curr Opin Rheumatol; 2001 May; 13(3):159-63. PubMed ID: 11333342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.